ArticleAmerican journal of translational research2025
Efficacy of a pubic superior ramus approach versus a distal approach for obturator nerve block in transurethral bladder tumor resection: a randomized controlled trial.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to compare the clinical efficacy and safety of a modified pubic superior ramus (PSS) approach for pericapsular nerve group block against the conventional distal technique in obturator nerve blockade during transurethral resection of bladder tumor (TURBT), with a focus on preventing intraoperative obturator nerve reflex.
methodsWe conducted a prospective, randomized, single-blind trial involving 70 patients scheduled for TURBT under general anesthesia. Participants were randomly assigned to one of two groups: Group P (n = 34) received ultrasound-guided obturator nerve block via the pubic superior ramus approach, while Group O (n = 34) underwent blockade via the distal approach. The primary outcome measures were the incidence and severity of obturator nerve reflex. Secondary outcomes encompassed block performance time and success rate, postoperative pain profiles (assessed by VAS scores), recovery quality, perioperative inflammatory biomarker levels, hemodynamic fluctuations, functional recovery metrics, as well as long-term bladder function and oncological outcomes evaluated at 6 and 12 months postoperatively.
resultsGroup P demonstrated significantly faster onset and greater reduction in adductor muscle strength at all measured time points (P < 0.05), with shorter block performance times (175.5 ± 34.2 vs. 223.7 ± 39.6 seconds, P < 0.001) and fewer needle passes (P < 0.001). While the incidence of the obturator reflex was similar between the groups, Group P had superior postoperative analgesia with lower pain scores, reduced morphine consumption (15.2 ± 4.8 vs. 24.5 ± 6.1 mg, P < 0.001), and a longer time to first analgesia. The quality of recovery scores was significantly greater in Group P at 24 and 48 hours (P < 0.001), along with an attenuated systemic inflammatory and neurochemical stress response (e.g., IL-6, Substance P, and c-Fos), improved hemodynamic stability, faster quadriceps recovery, and better short- and long-term bladder function. At the 12-month follow-up, Group P exhibited superior urodynamic parameters (Qmax and PVR, P < 0.01) and a trend towards lower tumor recurrence (94.1% vs. 85.3% recurrence-free survival, P = 0.218).
conclusionCompared with the distal approach, the pubic superior ramus approach for obturator nerve block provides more efficient blockade and superior multidimensional perioperative benefits, making it an optimal technique for TURBT within enhanced recovery protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.